You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
基蛋生物(603387.SH):上半年在全國共計召開12場經銷商會議,相應的會展及宣傳費同比增長較多
格隆匯 09-12 19:42

格隆匯9月12日丨基蛋生物(603387.SH)在半年度業績網上説明會上表示,2022年受疫情防控影響,公司產品的市場推廣受到一定程度的阻力,今年上半年公司加強市場拓展力度,上半年在全國共計召開12場經銷商會議,相應的會展及宣傳費同比增長較多;醫藥反腐是我國醫療體制改革的重要一環,是推動醫療行業公平競爭、提高醫療質量、保障患者權益的必然選擇。公司自成立以來始終堅持“追求卓越,傳遞健康”的經營理念,在經營過程中以守法合規經營為底線,嚴格履行法律法規和廉潔自律要求。長期來看,醫療反腐會進一步提高合規企業和優質創新企業的競爭優勢,減少醫療產業鏈中的不合理競爭,有利於促進公司可持續健康發展。在醫藥領域反腐的背景下,公司也將繼續以合法合規經營為底線,依託豐富的技術平台、深厚的研發技術積累、全產業鏈建設等優勢不斷夯實創新研發能力,持續推出具有創新優勢且滿足臨牀市場需求的多序列產品,為終端提供更多更全面的解決方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account